Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Carole Bradley"'
Autor:
Rita Selby, Lisa Kaus, Faith Sealey, Marika Koo, Sameer Parpia, Brian Chan, Soo Jin Seung, Carole Bradley, Rachel Strauss, Nicole Mittmann
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0284425 (2023)
BackgroundDespite the fact that direct oral anticoagulants (DOACs) are favoured over warfarin for stroke prevention in patients with non-valvular atrial fibrillation (NVAF), physicians need to maintain competence in using and monitoring warfarin sinc
Externí odkaz:
https://doaj.org/article/e40026a9cfe54f6e9d8ea28cef6c7d1d
Publikováno v:
Canadian Respiratory Journal, Vol 14, Iss 1, Pp 25-29 (2007)
BACKGROUND AND OBJECTIVE: Inhaled beta-agonist, anticholinergic and glucocorticoid medications are used to treat asthma and chronic obstructive pulmonary disease (COPD). The present study assessed the patterns of persistence with the above mentioned
Externí odkaz:
https://doaj.org/article/99c913bf2cb945d6aa13da3876fe8bea
Autor:
J Mark FitzGerald, Jennifer M Haddon, Carole Bradley-Kennedy, Lisa Kuramoto, Gordon T Ford, The RUSIC Study Group
Publikováno v:
Canadian Respiratory Journal, Vol 14, Iss 3, Pp 145-152 (2007)
BACKGROUND: There is increasing interest in health care resource use (HRU) in Canada, particularly in resources associated with acute exacerbations of chronic obstructive pulmonary disease (COPD).
Externí odkaz:
https://doaj.org/article/9ae08c85dfa04eec813cc85323906699
Publikováno v:
Canadian Respiratory Journal, Vol 14, Iss 1, Pp 25-29 (2007)
BACKGROUND AND OBJECTIVE: Inhaled beta-agonist, anticholinergic and glucocorticoid medications are used to treat asthma and chronic obstructive pulmonary disease (COPD). The present study assessed the patterns of persistence with the above mentioned
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cdce44acb76ab4b999b2e3f00d17827
https://doi.org/10.1155/2007/161652
https://doi.org/10.1155/2007/161652
Autor:
Michael Sharma, Sonja V. Sorensen, Anuraag R. Kansal, Siyang Peng, Neil Roskell, Brigitta U. Monz, Andreas Clemens, Carole Bradley-Kennedy
Publikováno v:
Thrombosis and haemostasis. 108(4)
SummaryCanadian patients with atrial fibrillation (AF) in whom anticoagulation is appropriate have two new choices for anticoagulation for prevention of stroke and systemic embolism – dabigatran etexilate (dabigatran) and rivaroxaban. Based on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8ac2b4af63782c702cc7d518b29a547
https://pubmed.ncbi.nlm.nih.gov/22898892
https://pubmed.ncbi.nlm.nih.gov/22898892
Autor:
Anuraag R. Kansal, Carole Bradley-Kennedy, Jonathan M. Plumb, Stuart J. Connolly, Siyang Peng, John E Linnehan, Sonja V. Sorensen
Publikováno v:
Thrombosis and haemostasis. 105(5)
SummaryOral dabigatran etexilate is indicated for the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF) in whom anticoagulation is appropriate. Based on the RE-LY study we investigated the cost-effectiveness of Heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29d61e094675a58468871a5e14833ffc
https://pubmed.ncbi.nlm.nih.gov/21431243
https://pubmed.ncbi.nlm.nih.gov/21431243
Publikováno v:
Pharmacoeconomics
Background A number of models exploring the cost-effectiveness of dabigatran versus warfarin for stroke prevention in atrial fibrillation have been published. These studies found dabigatran was generally cost-effective, considering well-accepted will
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2928db3536a672e8e9ea3ede95e84c00